Randomized, Double-Blind, Placebo-Controlled International Clinical Trial of the AMPAKINE^® CX516 in Elderly Participants with Mild Cognitive Impairment

By Johnson S.A.   Simmon V.F.  

Journal of Molecular Neuroscience, Vol. 19, Iss. 1-2, 2002-10 ,pp. : 197-200

Humana Press, Inc

Access to resources Recommend Favorite

Training of attentional control in mild cognitive impairment with executive deficits: Results from a double-blind randomised controlled study

By Gagnon Lyssa G.   Belleville Sylvie  

Neuropsychological Rehabilitation, Vol. 22, Iss. 6, 2012-12 ,pp. : 809-835

Routledge Ltd

Access to resources Recommend Favorite

Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy

By Sharief M.   Viteri C.   Ben-Menachem E.   Weber M.   Reife R.   Pledger G.   Karim R.  

Epilepsy Research, Vol. 25, Iss. 3, 1996-11 ,pp. : 217-224

Elsevier

Access to resources Recommend Favorite

Treatment with sumatriptan 50 mg in the mild phase of migraine attacks in patients with infrequent attacks: a randomised, double-blind, placebo-controlled study

By Tfelt-Hansen P.   Bach F.   Daugaard D.   Tsiropoulos I.   Riddersholm B.  

The Journal of Headache and Pain, Vol. 7, Iss. 6, 2006-12 ,pp. : 389-394

Springer Publishing Company

Access to resources Recommend Favorite

Rofecoxib in Patients with Mild Cognitive Impairment: Further Analyses of Data from a Randomized, Double-Blind, Trial

By  

Current Alzheimer Research, Vol. 5, Iss. 1, 2008-02 ,pp. : 73-82

Bentham Science Publishers

Access to resources Recommend Favorite